Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition ...

Fintel reports that on May 29, 2026, Cantor Fitzgerald initiated coverage of Sensei Biotherapeutics (NasdaqCM:SNSE) with a Overweight recommendation. Analyst Price Forecast Suggests 189.94% Upside As ...

Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline across key clinical milestones in endometrial and breast cancer PIKTOR is an ...

Today, Sensei announced the launch of Sensei Cloud Apps, a new cloud-based platform designed to help dental practices start each day prepared, stay connected to patients, and operate more efficiently ...

A new app called Sensei has arrived today for Mac that lets you monitor and tweak performance to get the most out of your machine. Sensei features a beautiful user interface with rich icons and lots ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its immune checkpoint inhibitor through phase 2. The asset in question, dubbed ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

Leading luxury wellness brand Sensei — known for some of the world’s most unique and exclusive wellness destinations, programs, and retreats —has launched Collections, a new curated suite of services ...

In today’s challenging economic climate, small businesses are constantly battling financial obstacles. Lead Sensei, under the leadership of CEO Daniel Bradley, is stepping in as a ...